22NW, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001694297

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q1 2025 · 20 positions · Total reported value $149.09M · Top-10 concentration 85.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.9% · 4 new · 0 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.8% · Prev Value $104.68M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.3% · vs SPY -3.4% · Latest Value $144.32M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, 22NW, LP disclosed 20 equity positions with a combined reported value of $149.09M. The filing implies a focused portfolio: its ten largest positions account for 85.6% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q1 2025 were LFCR ($29.82M), FSTR ($25.84M), ANEB ($20.11M). By sector, the heaviest allocations are Health Care 33.0%, Industrials 24.9%. Versus the prior quarter, allocation shifted toward Health Care (+10.1pp), Consumer Discretionary (+1.6pp) and away from Materials (-2.9pp), Industrials (-10.0pp).

Versus the prior quarter, 22NW, LP opened 4 new positions, trimmed 0 and fully exited 3, a turnover rate of 38.9% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q1 2025 were MLYS ($7.33M), RGNX ($4.78M), ELDN ($2.16M).

Of the 3 positions fully exited versus the prior quarter, the largest were MTW ($3.25M), LNTH ($3.09M), PMDI ($618.32K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • MLYS MINERALYS THERAPEUTICS INC · $7.33M
  • RGNX REGENXBIO INC · $4.78M
  • ELDN ELEDON PHARMACEUTICALS INC · $2.16M
  • CMPS COMPASS PATHWAYS PLC · $1.85M
  • KROS KEROS THERAPEUTICS INC · $1.82M
  • PMD PSYCHEMEDICS CORP · $643.16K
  • TISI TEAM INC · $589.41K

Fully Exited (vs previous quarter)

  • MTW MANITOWOC CO INC · prev qtr: $3.25M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $3.09M
  • PMDI PSYCHEMEDICS CORP · prev qtr: $618.32K

Insider Transactions (Form 4)

Latest 22NW, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

22NW LP, based in Seattle, WA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 14 positions worth $104.68M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SEATTLE, WA, United States
  • SEC registration: 801-110797 (status: Approved), registered 2017-07-25
  • Regulatory AUM (Form ADV): $295.59M as of 2026-03-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: englishcap.com

Portfolio Structure

  • 14 positions · $104.68M reported value (Q2 2026)
  • Top 10 holdings = 94.6% of reported value
  • Largest position: NSP (INSPERITY INC) at 19.5%
  • Average position size: $7.48M

Sector Tilt

  • Consumer Discretionary 59.9%
  • Health Care 33.8%
  • Industrials 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 added, 1 reduced, 3 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 33.0%
Industrials 24.9%
Materials 13.5%
Financials 4.2%
Other 4.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.76M $29.82M 20.00%
20.00%
Hold
2 1.31M $25.84M 17.33%
17.33%
Hold
3 15.47M $20.11M 13.49%
13.49%
Hold
4 99.78K $11.30M 7.58%
7.58%
Hold
5 1.86M $9.30M 6.24%
6.24%
Add
6 1.63M $7.47M 5.01%
5.01%
Add
7 461.34K $7.33M 4.91%
4.91%
New
8 117.89K $6.25M 4.19%
4.19%
Hold
9 132.45K $5.45M 3.66%
3.66%
Reduce
10 668.68K $4.78M 3.21%
3.21%
New
11 1.96M $4.34M 2.91%
2.91%
Hold
12 2.60M $3.62M 2.43%
2.43%
Hold
13 731.53K $3.52M 2.36%
2.36%
Add
14 636.36K $2.16M 1.45%
1.45%
New
15 646.56K $1.85M 1.24%
1.24%
New
16 179.00K $1.82M 1.22%
1.22%
New
17 2.19M $1.49M 1.00%
1.00%
Hold
18 537.00K $1.42M 0.95%
0.95%
Hold
19 276.03K $643.16K 0.43%
0.43%
New
20 34.84K $589.41K 0.40%
0.40%
New

FAQ

What did 22NW, LP buy in 2025-Q1?

In its 2025-Q1 13F filing, 22NW, LP reported 20 equity positions worth $149.09M in aggregate; its largest disclosed positions were LFCR ($29.82M), FSTR ($25.84M), ANEB ($20.11M).

How large is 22NW, LP's portfolio?

22NW, LP reported $149.09M of long equity holdings across 20 positions as of 2025-Q1. Top-10 holdings account for 85.6% of reported value.

What is 22NW, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/22nw/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →